{"id":2595,"date":"2018-09-01T12:07:00","date_gmt":"2018-09-01T10:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2018\/leserbrief-zur-indikation-einer-dualen-oder-dreifachen-antithrombotischen-therapie"},"modified":"2022-03-17T14:13:48","modified_gmt":"2022-03-17T13:13:48","slug":"leserbrief-zur-indikation-einer-dualen-oder-dreifachen-antithrombotischen-therapie","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2018\/leserbrief-zur-indikation-einer-dualen-oder-dreifachen-antithrombotischen-therapie","title":{"rendered":"Leserbrief: Zur Indikation einer dualen oder dreifachen antithrombotischen Therapie"},"content":{"rendered":"<p>Frage von Dr. U.S. aus H.: >> Aufgrund des interessanten Beitrags in der Ausgabe Juni 2018 des AMB w\u00fcrde ich gerne noch zu dem gesamten Thema Fragen stellen, da hier aus Kliniken nach Gef\u00e4\u00dfeingriffen diverse nicht nachvollziehbare Entlassmedikationen auftauchen. Nach Stent-Implantationen kam es hier zuletzt zu Entlassmedikationen mit einer Tripel-Therapie von Apixaban, Azetylsalizyls\u00e4ure (ASS) plus [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von Dr. U.S. aus H.: >> Aufgrund des interessanten Beitrags in der Ausgabe Juni 2018 des AMB w\u00fcrde ich gerne noch zu dem gesamten Thema Fragen stellen, da hier aus Kliniken nach Gef\u00e4\u00dfeingriffen diverse nicht nachvollziehbare Entlassmedikationen auftauchen. Nach Stent-Implantationen kam es hier zuletzt zu Entlassmedikationen mit einer Tripel-Therapie von Apixaban, Azetylsalizyls\u00e4ure (ASS) plus [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[185,74,137,60,77,76,73,1314,1312,187,68,1328,1327,83,84,87,138,1033,79,183,2304,56,882,54,2005,4833,181,136],"class_list":["post-2595","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-absolute-arrhythmie","tag-acetylsalicylsaeure","tag-antikoagulanzien","tag-apoplektischer-insult","tag-ass","tag-azetylsalizylsaeure","tag-clopidogrel","tag-direkte-orale-antikoagulanzien","tag-doak","tag-herzrhythmusstoerungen","tag-hirninfarkt","tag-neue-orale-antikoagulanzien","tag-noak","tag-pci","tag-perkutane-koronarintervention","tag-perkutane-transluminale-koronare-angioplastie","tag-phenprocoumon","tag-prasugrel","tag-ptca","tag-rhythmusstoerungen","tag-rivaroxaban","tag-schlaganfall","tag-stent","tag-thromboembolie","tag-ticagrelor","tag-tripel-therapie","tag-vorhofflimmern","tag-warfarin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2595"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2595\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}